Stephen Doster
-
A potential new approach for the treatment of schizophrenia
THE IDEA Jeffrey Conn (John Russell/Vanderbilt University) James Maksymetz A new study led by Jeff Conn, Lee E. Limbird Chair in Pharmacology, James Maksymetz, a former graduate student in the Conn laboratory, and other collaborators at the Warren Center for… Read MoreDec. 8, 2021
-
Deciphering the Circuits in Neuroscience Research
Around 500 million people around the world are affected by poor mental health including disorders such as depression, schizophrenia, bipolar disease and dementia with a significant impact on quality of life as well as associated social and economic consequences.1 Boehringer Ingelheim is dedicated to redefining the management of mental health. Read MoreDec. 7, 2021
-
Flipping the script on flippases
Todd Graham, Stevenson Chair of Biological Sciences and professor of cell and developmental biology, and external collaborators recently published a paper describing the structure of a yeast “flippase” called Neo1. The research was led by three co-first authors: Bhawik Jain, a postdoc from the Graham lab, Lin Bai from Peking… Read MoreDec. 6, 2021
-
Calipari named Dean’s Faculty Fellow
Erin Calipari, assistant professor of pharmacology and member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early stages of… Read MoreDec. 1, 2021
-
Six from Vanderbilt among most highly cited researchers
Six current faculty members at Vanderbilt University Medical Center have made this year’s list of scientists whose papers have been cited most frequently by other researchers. They are among 6,600 researchers around the world identified by the global analytics firm Clarivate whose publications rank in the top 1% by… Read MoreNov. 24, 2021
-
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Burkewitz was one of 10… Read MoreNov. 22, 2021
-
Mosquitoes have a mutual symbiotic relationship with malaria-causing pathogen
Cornelius Vanderbilt Professor of Biological Sciences Laurence J. Zwiebel is part of a team of researchers at Vanderbilt and the Johns Hopkins Malaria Research… Read MoreNov. 19, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, has conducted pioneering research on some of the most difficult drug discovery targets in cancer research. As a result of his lab’s discoveries, molecule-specific data has been made freely available for download to cancer researchers on the opensource platform opnMe.com, which… Read MoreNov. 15, 2021
-
Learn about the science of longevity with Vanderbilt experts in virtual event
Biomedical science has made huge strides in understanding the mechanics of human aging, and these discoveries have drastically affected how we work to prevent disease and increase longevity. On Tuesday, Nov. 30, 11 a.m.–noon CT, the School of Medicine Basic Sciences’ monthly virtual Lab-to-Table Conversation will bring aging research experts… Read MoreNov. 15, 2021
-
Former Chair of Biochemistry Michael Waterman dies
On Sunday, November 7, Michael Waterman, former chair of the Department of Biochemistry, passed away. Waterman was chair of biochemistry for 18 years and helped develop the department into a place where faculty could thrive. “Mike believed in empowering faculty,” David Cortez, current chair of the department, said. “He always… Read MoreNov. 12, 2021